Pemetrexed Pfizer (previously Pemetrexed Hospira) Evrópusambandið - íslenska - EMA (European Medicines Agency)

pemetrexed pfizer (previously pemetrexed hospira)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - Æxlishemjandi lyf - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Steglatro Evrópusambandið - íslenska - EMA (European Medicines Agency)

steglatro

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic sýru - sykursýki, tegund 2 - drugs used in diabetes, sodium-glucose co-transporter 2 (sglt2) inhibitors - steglatro er ætlað í fullorðnir 18 ára og eldri með tegund 2 sykursýki sem viðbót til að fæði og æfa til að bæta blóðsykursstjórnun:eitt og sér í sjúklingar sem notkun kvarta er talið óviðeigandi vegna óþol eða frábendingar. auk þess önnur lyf fyrir meðferð sykursýki.

Movicol Junior Neutral Mixtúruduft, lausn 6,9 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

movicol junior neutral mixtúruduft, lausn 6,9 g

norgine healthcare b.v. - macrogol 3350; sodium hydrogen carbonate; kalii chloridum; sodium chloride - mixtúruduft, lausn - 6,9 g

Movicol Mixtúruduft, lausn 13,8 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

movicol mixtúruduft, lausn 13,8 g

norgine healthcare b.v. - macrogol 3350; sodium chloride; sodium hydrogen carbonate; kalii chloridum - mixtúruduft, lausn - 13,8 g

Phoxilium Blóðskilunar-/blóðsíunarlausn 1,2 mmol/l Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

phoxilium blóðskilunar-/blóðsíunarlausn 1,2 mmol/l

baxter holding b.v.* - calcium chloride; magnesii chloridum; sodium chloride; sodium hydrogen carbonate; kalii chloridum; disodium phosphate dodecahydrate - blóðskilunar-/blóðsíunarlausn - 1,2 mmol/l

Soluprick SQ (Grass Pollen) Húðstungupróf, lausn 10 HEP Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

soluprick sq (grass pollen) húðstungupróf, lausn 10 hep

alk-abelló a/s - phleum pratense; avena elatior; alopecurus pratensis; secale cereale; poa pratensis; dactylis glomerata; festuca pratensis; lolium perenne - húðstungupróf, lausn - 10 hep

Xylocain Stungulyf, lausn 10 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 10 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 10 mg/ml

Xylocain Stungulyf, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 20 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Xylocain adrenalin Stungulyf, lausn 10 mg/ml+5 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml

aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml

Adrovance Evrópusambandið - íslenska - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - beinþynning, eftir tíðahvörf - lyf til að meðhöndla beinsjúkdóma - meðferð við beinþynningu eftir tíðahvörf hjá sjúklingum í hættu á d-vítamínskorti. hættan dregur úr hættu hryggjarliðum og mjöðm beinbrot.